INTERNATIONAL PATENT: SUNRISE ONCOLOGY (HONG KONG) LIMITED FILES APPLICATION FOR "RAS INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF"

GENEVA, April 6 -- SUNRISE ONCOLOGY (HONG KONG) LIMITED (Suite 603, 6F Laws Commercial Plaza788 Cheung Sha Wan RoadHong Kong) filed a patent application (PCT/IB2025/000495) for "RAS INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF" on Sep 30, 2025. With publication no. WO/2026/069006, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TONG, Xiaotian (Room 1001, Building 1, No. 58, Tanzhu RoadMinhang District,Shanghai, 201100), ZHOU, Wenbo (Room 1001, Building 1, No. 58, Tanzhu RoadMinhang District,Shanghai, 2011...